Impact of comorbidity on patient reported outcome measures for men with localised prostate cancer

By afschroeder • April 20, 2026

Parry MG, Bailey AV, Belin TR, Elashoff D, Foster C, Graham I, Kowalski C, Kwan L, Millar J, Sibert NT, Weller S, Wilhalme H, Litwin MS, Moore CM; TrueNTH Global Registry. Impact of comorbidity on patient reported outcome measures for men with localised prostate cancer. BMC Urol. 2026 Apr 18. doi: 10.1186/s12894-026-02146-w. Epub ahead of print. PMID: 42001072.

Tags: comorbidities, DOM STAT, Functional outcomes, General Internal Medicine, International Registry, patient-reported outcome measures, prostate cancer, Publications

Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right Atrial Rupture

Makaroff KE, Hampilos K, Sayed S, Emert B, Hu X, Nsair A, Kwon M, Middlekauff H. Primary Cardiac Angiosarcoma Leading to Tamponade and Fatal Right[...]

Long COVID Persistence and Surveillance Gaps Across 58 US Hospitals

Tian J, Azhir A, Decaro M, Chau N, Hügel J, Morris M, Cheng J, Fard P, Bassett IV, Bell DS, Bernstam EV, Visweswaran S, Klann[...]

Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among Veterans with Prediabetes by Race and Ethnicity, 2010-2019

Ly DP, Washington DL, Shekelle PG, Lee ML, Moin T. Use of Evidence-Based Type 2 Diabetes Preventive Therapies and Rates of Progression to Diabetes Among[...]